Literature DB >> 6950169

Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin.

P Boukamp, W Tilgen, R T Dzarlieva, D Breitkreutz, D Haag, R K Riehl, A Bohnert, N E Fusenig.   

Abstract

A human cell line (SCL-1) from a poorly differentiating cutaneous squamous cell carcinoma (SCC) ws studied through 20 passages during 2 years. Cells maintained their original morphology with low degree of keratinization, as indicated by light and electron microscopy. The keratin peptide pattern resembled the type in SCC tumors, and the corresponding filaments were detected by immunofluorescence at all passage levels. Cells did not grow in soft agar but formed tumor-like nodules in an "organotypic" culture assay (on lifted collagen gels) and grew invasively after transplantation to immunosuppressed inbred C3H mice. After injection into BALB/c nu/nu mice, tumors of SCC morphology were formed. The hypodiploid tumor stem-line was maintained for about 10 passages, when a shift to hyperploidy started, as determined by chromosome and DNA flow microfluorometric analyses. Two stable marker chromosomes (in 100 and 70% of the metaphases, respectively), involving chromosomes 7 and 9, strongly indicated a monoclonal origin of this cell line.

Entities:  

Mesh:

Year:  1982        PMID: 6950169

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  23 in total

1.  Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes.

Authors:  C Härle-Bachor; P Boukamp
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Epithelial-mesenchymal interactions control basement membrane production and differentiation in cultured and transplanted mouse keratinocytes.

Authors:  A Bohnert; J Hornung; I C Mackenzie; N E Fusenig
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Evidence for two points of restriction in the expression of adenovirus type 2 in cultured epidermal keratinocytes.

Authors:  B J Aneskievich; L B Taichman
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  Detection and separation of the submetacentric marker chromosome of the WALKER (W-256) carcinoma using flow cytometry and sorting.

Authors:  K J Hutter; M Stoehr
Journal:  Histochemistry       Date:  1985

5.  Generation of adhesive tumor variants: chromosomal changes, reduction in malignancy and increased expression of a distinct membrane glycoprotein.

Authors:  E Pflüger; E Lang; R Benke; B Heckl-Ostreicher; P Altevogt; V Schirrmacher
Journal:  Clin Exp Metastasis       Date:  1988 Nov-Dec       Impact factor: 5.150

6.  Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization.

Authors:  K Bleuel; S Popp; N E Fusenig; E J Stanbridge; P Boukamp
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  A new model of epidermal differentiation: induction by mechanical stimulation.

Authors:  F E Görmar; A Bernd; J Bereiter-Hahn; H Holzmann
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

8.  Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors.

Authors:  R J Tatake; N Rajaram; R N Damle; B Balsara; A N Bhisey; S G Gangal
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

9.  Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation.

Authors:  J Hornung; A Bohnert; L Phan-Than; T Krieg; N E Fusenig
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

10.  Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells.

Authors:  B Chesebro; R Buller; J Portis; K Wehrly
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.